Auckland: Researchers at the University of Auckland have provided the first strong evidence on how Parkinson’s disease spreads in the brain, helping to advance treatment of the disease. In a paper, published today in Scientific Reports – Nature, the study revealed that pathological proteins (known as Lewy bodies) in Parkinson’s disease could be spread from cell to cell. “This theory of Parkinson’s disease spread is topical, but here we have the first proof in cell culture of the mechanism controlling the spread,” says Associate Professor Maurice Curtis from the University’s Centre for Brain Research, who leads the Centre’s research on Parkinson’s disease.
“The implication is that if there is a spread of the Lewy bodies in
the brain then the spread could be stopped early on,” he says. “This new
mechanism of pathology spread provides us with new targets to go after
for development of Parkinson’s disease treatments.
“The traditional way of thinking about Parkinson’s was that there was
a susceptible area in the brain and if you could fix that area then the
next most susceptible area would soon be affected,” says Dr Curtis.
“But if the Parkinson’s disease pathology spreads then it may be
possible to stop it in its tracks.
“The mechanism that cells use to spread the Lewy bodies is via
structures called tunneling nanotubes that act like conduits between two
cells through which large proteins can pass.
“Our work also demonstrated that non-neuronal cells, in this case
cells in the blood vessels called pericytes, appear to harbour and
spread the Lewy bodies rather than just the neurons,” says Dr Curtis.
“Most literature suggests that Lewy bodies cause the most problems in
neurons but this paper proposes blood vessel pericytes to be
Dr Curtis says, “this has been a major push in my laboratory and I am
proud of this work by our team, including post-doctoral researcher and
lead author, Dr Victor Dieriks.
“This vital work was funded by the Neuro Research Charitable Trust
founded by Bernie and Kaye Crosby who have fund-raised to support this
work and who have been strong advocates for Parkinson’s disease research
in New Zealand,” he says.
“This work was also made possible because of the availability of
human brain cells cultured postmortem from those who donate their brain
to advance research, provided by the Centre’s Human Brain Bank,” says Dr
For media enquiries email Suzi Phillips, Media Advisor Medical and Health Sciences.